Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 3
2006 2
2007 2
2008 10
2009 22
2010 26
2011 23
2012 20
2013 20
2014 14
2015 13
2016 8
2017 11
2018 7
2019 5
2020 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21082960

161 results

Results by year

Filters applied: . Clear all
Page 1
Plerixafor: a peripheral blood stem cell mobilizer.
Kessans MR, Gatesman ML, Kockler DR. Kessans MR, et al. Pharmacotherapy. 2010 May;30(5):485-92. doi: 10.1592/phco.30.5.485. Pharmacotherapy. 2010. PMID: 20411999 Review.
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz MJ, Langston A, Prichard JM, Anderson D, Gleason C, Lonial S, Flowers CR, Kaufman JL, Waller EK. Li J, et al. Transfusion. 2011 Oct;51(10):2175-82. doi: 10.1111/j.1537-2995.2011.03136.x. Epub 2011 Apr 14. Transfusion. 2011. PMID: 21492180
Plerixafor (Mozobil).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Apr 5;52(1335):27-8. Med Lett Drugs Ther. 2010. PMID: 20360661 No abstract available.
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.
Brave M, Farrell A, Ching Lin S, Ocheltree T, Pope Miksinski S, Lee SL, Saber H, Fourie J, Tornoe C, Booth B, Yuan W, He K, Justice R, Pazdur R. Brave M, et al. Oncology. 2010;78(3-4):282-8. doi: 10.1159/000315736. Epub 2010 Jun 8. Oncology. 2010. PMID: 20530974
Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.
Stiff P, Micallef I, McCarthy P, Magalhaes-Silverman M, Weisdorf D, Territo M, Badel K, Calandra G. Stiff P, et al. Biol Blood Marrow Transplant. 2009 Feb;15(2):249-56. doi: 10.1016/j.bbmt.2008.11.028. Biol Blood Marrow Transplant. 2009. PMID: 19167685 Free article. Clinical Trial.
161 results